If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Mayur Garg is a Melbourne gastroenterologist, with a wide range of clinical and research interests in all aspects of luminal gastroenterology, including:

·        Inflammatory bowel disease (IBD),

·        Endoscopy, including bowel cancer screening and removal of large polyps

·        Functional gastrointestinal disorders (including irritable bowel syndrome),

·        Iron deficiency, and

·        Peptic ulcer disease

Mayur graduated with his MBBS from the University of Melbourne in 2003, and has since worked at several of Melbourne’s leading hospitals. He has been awarded a PhD from Monash University which investigated the role of the renin-angiotenin system and vitamin D in IBD, and has won several competitive scholarships in endoscopy and IBD – including the Gastroenterological Society of Australia Endoscopy Fellowship at the world’s leading colonoscopy centre, St Mark’s Hospital in London, and European Crohn’s and Colitis Organisation Fellowship (awarded to only two applicants worldwide per year), from 2014-2015.

He is currently Acting Head of Inflammatory Bowel Disease at Royal Melbourne Hospital, Clinical Associate Professor at University of Melbourne, and Adjunct Senior Lecturer at Monash University.

Mayur has a passion for excellence in patient care and service quality, and is a believer in patients participating and being empowered in their management. He has published numerous papers in esteemed scientific journals, and maintains an active research portfolio. He is frequently invited to present at local, national and international conferences.

External positions

Clinical Associate Professor, The University of Melbourne

18 Jun 2019 → …

Acting Head of IBD, The Royal Melbourne Hospital

22 Apr 2019 → …

Consultant Gastroenterologist, Eastern Health

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2019

Research Output 2011 2019

Letters: low FODMAP diet-directions for future research and the low FODMAP diet is not the only diet for IBS-authors' reply

Mitchell, H., Porter, J., Gibson, P. R., Barrett, J. & Garg, M., 1 Apr 2019, In : Alimentary Pharmacology and Therapeutics. 49, 8, p. 1109-1110 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Open Access

Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research

Mitchell, H., Porter, J., Gibson, P. R., Barrett, J. & Garg, M., 1 Jan 2019, In : Alimentary Pharmacology and Therapeutics. 49, 2, p. 124-139 16 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File

Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease

Garg, M., Rosella, O., Rosella, G., Wu, Y., Lubel, J. S. & Gibson, P. R., Aug 2018, In : Clinical Nutrition. 37, 4, p. 1375-1382 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

Flanagan, E., Gibson, P. R., Begun, J., Ghaly, S., Garg, M., Andrews, J. M., Rosella, O., Rosella, G. & Bell, S. J., 1 Dec 2018, In : Alimentary Pharmacology and Therapeutics. 48, 11-12, p. 1328-1330 3 p.

Research output: Contribution to journalLetterOtherpeer-review